- Home
- SIG vs XENE Comparison
SIG vs XENE Comparison
Compare SIG & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIG
- XENE
- Stock Information
- Founded
- SIG 1950
- XENE 1996
- Country
- SIG Bermuda
- XENE Canada
- Employees
- SIG N/A
- XENE N/A
- Industry
- SIG Consumer Specialties
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- SIG Consumer Discretionary
- XENE Health Care
- Exchange
- SIG Nasdaq
- XENE Nasdaq
- Market Cap
- SIG 2.5B
- XENE 2.5B
- IPO Year
- SIG N/A
- XENE 2014
- Fundamental
- Price
- SIG $55.38
- XENE $35.11
- Analyst Decision
- SIG Buy
- XENE Strong Buy
- Analyst Count
- SIG 4
- XENE 8
- Target Price
- SIG $71.50
- XENE $56.38
- AVG Volume (30 Days)
- SIG 1.7M
- XENE 870.9K
- Earning Date
- SIG 06-12-2025
- XENE 05-08-2025
- Dividend Yield
- SIG 2.31%
- XENE N/A
- EPS Growth
- SIG N/A
- XENE N/A
- EPS
- SIG N/A
- XENE N/A
- Revenue
- SIG $6,703,800,000.00
- XENE N/A
- Revenue This Year
- SIG $0.75
- XENE N/A
- Revenue Next Year
- SIG $1.27
- XENE $1,553.36
- P/E Ratio
- SIG N/A
- XENE N/A
- Revenue Growth
- SIG N/A
- XENE N/A
- 52 Week Low
- SIG $45.55
- XENE $26.74
- 52 Week High
- SIG $112.06
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- SIG 48.80
- XENE 55.88
- Support Level
- SIG $50.02
- XENE $32.35
- Resistance Level
- SIG $58.99
- XENE $34.08
- Average True Range (ATR)
- SIG 3.99
- XENE 2.43
- MACD
- SIG -0.29
- XENE 0.57
- Stochastic Oscillator
- SIG 48.34
- XENE 96.54
About SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.